Spinal muscular atrophy at the crossroads of basic science and therapy.

Spinal muscular atrophy at the crossroads of basic science and therapy.

Show other versions (1)

Bibliographic Details
Main Authors:	Sleigh, J, Grice, S, Davies, K, Talbot, K
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Spinal muscular atrophy at the crossroads of basic science and therapy
by: Sleigh, J, et al.
Published: (2013)

Spinal muscular atrophy.
by: Talbot, K, et al.
Published: (2001)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
by: Sleigh, J, et al.
Published: (2011)

Chapter 16 Spinal Muscular Atrophy
by: Talbot, K, et al.
Published: (2003)

Invertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.
by: Grice, S, et al.
Published: (2011)

Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
by: Grice, S, et al.
Published: (2011)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
by: James N. Sleigh, et al.
Published: (2011-07-01)

Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies.
by: Talbot, K, et al.
Published: (2007)

Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.
by: Sleigh, J, et al.
Published: (2014)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
by: Hammond, S, et al.
Published: (2016)

Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
by: Andrew P. Tosolini, et al.
Published: (2017-12-01)

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY
by: Theodosiou, A, et al.
Published: (1995)

Splice-switching therapy for spinal muscular atrophy.
by: Meijboom, K, et al.
Published: (2017)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
by: Wood, M, et al.
Published: (2017)

Model systems for exploring new therapeutic interventions and disease mechanisms in spinal muscular atrophies (SMAs)
by: Sleigh, JN
Published: (2012)

Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.
by: Anderson, K, et al.
Published: (2003)

Spinal muscular atrophy
by: D'Amico Adele, et al.
Published: (2011-11-01)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

Modelling of spinal muscular atrophy in D-melanogaster and C-elegans
by: Davies, K
Published: (2004)

Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington’s disease
by: Stuart J Grice, et al.
Published: (2023-01-01)

Rehabilitation in spinal muscular atrophy
by: Agus Iwan Foead, et al.
Published: (2019-01-01)

Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01)

Nusinersen for spinal muscular atrophy
by: Claudia D. Wurster, et al.
Published: (2018-03-01)

Spinal muscular atrophy and ependymoma
by: Aishah Albakr, et al.
Published: (2017-01-01)

INNOVATIVE THERAPIES IN GENETIC DISEASES: SPINAL MUSCULAR ATROPHY
by: Elena-Silvia Shelby, et al.
Published: (2021-06-01)

Review of respiratory therapies in patients with spinal muscular atrophy
by: V. Yu. Artemenko, et al.
Published: (2018-05-01)

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
by: Mutsaers, C, et al.
Published: (2011)

Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.
by: Bäumer, D, et al.
Published: (2009)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Melissa Bowerman, et al.
Published: (2017-08-01)

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
by: Sibylle Jablonka, et al.
Published: (2022-01-01)

Update on Biomarkers in Spinal Muscular Atrophy
by: Megan G Pino, et al.
Published: (2021-08-01)

Spinal muscular atrophy (Werdnig‑Hoffmann atrophy disease)
by: Mariana A. RYZNYCHUK, et al.
Published: (2018-06-01)

Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy
by: Wendy K. M. Liew, et al.
Published: (2013-05-01)

Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy
by: Jan Lejman, et al.
Published: (2021-08-01)

Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy
by: Wilfried Rossoll, et al.
Published: (2022-05-01)

Editorial: Spinal Muscular Atrophy: Evolutions and Revolutions of Modern Therapy
by: Richard S. Finkel, et al.
Published: (2020-07-01)

Gene therapy for spinal muscular atrophy: the benefit–cost profile
Published: (2021-07-01)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
by: Turner, B, et al.
Published: (2008)

Modeling spinal muscular atrophy in Drosophila.
by: Chang, H, et al.
Published: (2008)